FMR LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 226 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.7%.

Quarter-by-quarter ownership
FMR LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q3 2022$17,958,000
+4.9%
118,794
+1.1%
0.00%0.0%
Q2 2022$17,122,000
-90.7%
117,508
-92.4%
0.00%
-86.7%
Q1 2022$184,003,000
-11.6%
1,551,851
+2.7%
0.02%0.0%
Q4 2021$208,210,000
+17.0%
1,510,850
+17.9%
0.02%
+7.1%
Q3 2021$177,979,000
+60.8%
1,281,250
+12.4%
0.01%
+55.6%
Q2 2021$110,688,000
+44.8%
1,140,174
+2.0%
0.01%
+28.6%
Q1 2021$76,431,000
-34.1%
1,118,224
-17.4%
0.01%
-30.0%
Q4 2020$116,063,000
+29.4%
1,354,137
-1.9%
0.01%
+11.1%
Q3 2020$89,715,000
-9.3%
1,380,017
+2.0%
0.01%
-18.2%
Q2 2020$98,875,000
+267.6%
1,352,414
+71.1%
0.01%
+175.0%
Q1 2020$26,896,000
-29.5%
790,343
+12.9%
0.00%0.0%
Q4 2019$38,124,000
+30.5%
700,2790.0%0.00%0.0%
Q3 2019$29,216,000
+96.6%
700,279
+106.4%
0.00%
+100.0%
Q2 2019$14,861,000
-36.7%
339,363
-25.6%
0.00%
-33.3%
Q1 2019$23,489,000
-24.5%
456,367
-45.8%
0.00%
-25.0%
Q4 2018$31,109,000
-7.8%
841,232
-6.4%
0.00%0.0%
Q3 2018$33,751,000
-36.9%
898,832
-33.6%
0.00%
-33.3%
Q2 2018$53,513,000
+309.0%
1,354,064
+166.6%
0.01%
+200.0%
Q1 2018$13,084,000
-53.2%
507,923
-51.0%
0.00%
-33.3%
Q4 2017$27,938,000
-27.8%
1,035,5230.0%0.00%
-40.0%
Q3 2017$38,708,000
+49.5%
1,035,5230.0%0.01%
+66.7%
Q2 2017$25,888,0001,035,5230.00%
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q1 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 450,422$6,251,85714.11%
Liontrust Investment Partners LLP 134,659$7,478,9610.13%
Birchview Capital, LP 7,365$1020.07%
FNY Investment Advisers, LLC 250$30.00%
FNY Investment Advisers, LLC 18$00.00%
FNY Investment Advisers, LLC 56$00.00%
McElhenny Sheffield Capital Management, LLC 31$4300.00%
Blue Trust, Inc. 65$100.00%
IFP Advisors, Inc 1$10.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders